FOXA1 and posterior cortical atrophy: In summary, our study provides the first experimental evidence that distinct classes of FOXA1 alterations drive disparate PCa phenotypes (Fig. 5), while explaining the divergent evolution of Class 1 and Class 2 mutations in human disease.